AMGEN´s DE Website recently relaunched
The healthcare industry is extremely complex
due to
- regulatory issues
- direct-to-patient marketing and
- the powerful bond of privacy and trust between providers and patients.
Whether addressing physician or patient, we comprehend the fast changing issues involved in bettering the lives of patients.
The upside to better patient care is unlimited.
You know – we know
AMG, AMNOG, ATC, Benefit Assessment of Pharmaceuticals, BfArM, Biologics, Biosimilars, BLA, BMG, Breakthrough Therapy Designation, CHMP, CME, Compassionate Use, Compliance, DocCheck, EC, EMA, EPAR, FDA, G-BA, Generic, HCP, HWG, ICD-10, INN, IQWiG, Labelling, Lay Audience, Leaflet, MAA, MHRA, NCI, NDA, NICE, NIH, NPP (§ 73,3 AMG), NUB, OD, Off-Label-Use, Orphan Drugs, OL, OTC, PBM, PDUFA, PEI, Pharmacovigilance, Positive Opinion, Priority Review Designation, RA, Recombinant, Reference Prices, SGB V, Small Molecule …
CELGENE´s InSight Immunology relaunched:
Recently (re-)launched: GHD Website
115 Vertragspartner / Kostenträger 6.500.000 Jährliche Produktlieferungen
